Concurrent Chemoradiation | List of Frontiers open access articles

Original Research

Published on 31 May 2012

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer

in Radiation Oncology

Howard Safran
Thomas DiPetrillo
Humera Khurshid
Thomas Ng
Kalyan Mantripragada
Ariel Birnbaum
David Berz
Kathy Radie-Keane
Kimberly Perez
Maria Constantinou

Frontiers in Oncology

doi 10.3389/fonc.2012.00056

6,342 views
13 citations

Review

Published on 23 Jan 2018

Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer

in Radiation Oncology

Jennifer Lewis
Erin A. Gillaspie
Evan C. Osmundson
Leora Horn

Frontiers in Oncology

doi 10.3389/fonc.2018.00005

15,022 views
32 citations

Case Report

Published on 30 Apr 2025

Acquired ROS1 fusion and iruplinalkib response in advanced NSCLC after multiple lines of systematic therapy: a case report

in Cancer Molecular Targets and Therapeutics

Jiarui Liu
Zhichao Jiao
Jun Zhou
Yuan Yuan
Qiguang Li
Wei Zhou
Shuai Zhang
Shuping Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1571512

2,544 views

Review

Published on 08 Jul 2013

Image-Guided Radiotherapy for Locally Advanced Head and Neck Cancer

in Radiation Oncology

Nam Phong Nguyen
Sarah Kratz
Claire Lemanski
Jacqueline Vock
Vincent Vinh-Hung
Olena Gorobets
Alexander Chi
Fabio Almeida
Michael Betz
Rihan Khan

Frontiers in Oncology

doi 10.3389/fonc.2013.00172

9,680 views
8 citations

Perspective

Published on 04 Jul 2024

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

in Cancer Molecular Targets and Therapeutics

Nam Phong Nguyen
Ulf Lennart Karlsson
Brandi R. Page
Monica-Emilia Chirila
Vincent Vinh-Hung
Olena Gorobets
Meritxell Arenas
Mohammad Mohammadianpanah
Seyed Alireza Javadinia
Huan Giap

Frontiers in Oncology

doi 10.3389/fonc.2024.1371752

5,369 views

Review

Published on 18 Mar 2021

Status of Treatment and Prophylaxis for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer

in Radiation Oncology

Shiyu Liu
Qin Zhao
Zhuangzhuang Zheng
Zijing Liu
Lingbin Meng
Lihua Dong
Xin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2021.642575

23,289 views
75 citations

Systematic Review

Published on 27 Mar 2019

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol

in Neuro-Oncology and Neurosurgical Oncology

Kwanza T. Warren
Linxi Liu
Yang Liu
Michael T. Milano
Kevin A. Walter

Frontiers in Oncology

doi 10.3389/fonc.2019.00186

6,806 views
16 citations

Clinical Trial

Published on 27 Apr 2022

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin

in Head and Neck Cancer

Zhiyuan Xu
Li Yang
Wai-Tong Ng
Aya El Helali
Victor Ho-Fun Lee
Lingyu Ma
Qin Liu
Jishi Li
Lin Shen
Jijie Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.842281

2,992 views
2 citations

Original Research

Published on 14 Jul 2022

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Janna Berg
Ann Rita Halvorsen
May-Bente Bengtson
Morten Lindberg
Bente Halvorsen
Pål Aukrust
Åslaug Helland
Thor Ueland

Frontiers in Immunology

doi 10.3389/fimmu.2022.875152

5,733 views
6 citations

Original Research

Published on 18 Feb 2015

A Multi-Institutional Experience in Pediatric High-Grade Glioma

in Neuro-Oncology and Neurosurgical Oncology

Steve Walston
Daniel A. Hamstra
Kevin Oh
Gary Woods
Michael Guiou
Randal S. Olshefski
Arnab Chakravarti
Terence M. Williams

Frontiers in Oncology

doi 10.3389/fonc.2015.00028

5,525 views
20 citations

Case Report

Published on 07 Jan 2026

A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz–Jeghers syndrome: a case report and literature review

in Gynecological Oncology

Delu Wu
Xinyue Liu
Song Wang
Huanyu Zhang
Guofeng Qu
Lina Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1694187

733 views

Case Report

Published on 05 Mar 2025

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Xuesong Li
Bianhong Wang
Hao Liu
Zhuo Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528198

2,432 views
1 citation

Review

Published on 15 Dec 2022

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

in Thoracic Oncology

Yuki Mukai-Sasaki
Zhongxing Liao
David Yang
Tomio Inoue

Frontiers in Oncology

doi 10.3389/fonc.2022.984364

4,397 views
4 citations

Original Research

Published on 13 Dec 2011

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Ritsuko Komaki
Xiong Wei
Pamela K Allen
Zhongxing Liao
Luka Milas
James D Cox
Michael S O'Reilly
Joe Chang
Mary Frances McAleer
Melenda Jeter

Frontiers in Oncology

doi 10.3389/fonc.2011.00052

7,171 views
12 citations

Original Research

Published on 28 Jan 2026

Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapy

in Cancer Immunity and Immunotherapy

Saber A. Amin
Chi Lin
Apar K. Ganti
Weining Ken Zhen
Chi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1652522

689 views

Original Research

Published on 26 Sep 2025

Predicting radiation pneumonitis with dose-segmented radiomics in locally advanced non- small cell lung cancer patients undergoing consolidative immunotherapy post- concurrent chemoradiotherapy

in Cancer Immunity and Immunotherapy

Weiqing Wang
Yanan Wang
Xiaohan Wang
Jinming Yu
Xue Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1684629

2,590 views
1 citation

Articles

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer

Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer

Acquired ROS1 fusion and iruplinalkib response in advanced NSCLC after multiple lines of systematic therapy: a case report

Image-Guided Radiotherapy for Locally Advanced Head and Neck Cancer

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

Status of Treatment and Prophylaxis for Radiation-Induced Oral Mucositis in Patients With Head and Neck Cancer

The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin

Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer

A Multi-Institutional Experience in Pediatric High-Grade Glioma

A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz–Jeghers syndrome: a case report and literature review

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Role of Intermediate dose escalation of radiotherapy in the survival of unresectable stage III non-small cell lung cancer patients in the era of immunotherapy

Predicting radiation pneumonitis with dose-segmented radiomics in locally advanced non- small cell lung cancer patients undergoing consolidative immunotherapy post- concurrent chemoradiotherapy